These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26783524)

  • 1. Brain Parenchymal Fraction: A Relatively Simple MRI Measure to Clinically Distinguish ALS Phenotypes.
    Rajagopalan V; Pioro EP
    Biomed Res Int; 2015; 2015():693206. PubMed ID: 26783524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct patterns of cortical atrophy in ALS patients with or without dementia: an MRI VBM study.
    Rajagopalan V; Pioro EP
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Jun; 15(3-4):216-25. PubMed ID: 24555884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroimaging patterns along the ALS-FTD spectrum: a multiparametric imaging study.
    Omer T; Finegan E; Hutchinson S; Doherty M; Vajda A; McLaughlin RL; Pender N; Hardiman O; Bede P
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Nov; 18(7-8):611-623. PubMed ID: 28562080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graph theory network analysis provides brain MRI evidence of a partial continuum of neurodegeneration in patients with UMN-predominant ALS and ALS-FTD.
    Rajagopalan V; Pioro EP
    Neuroimage Clin; 2022; 35():103037. PubMed ID: 35597032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperintensity of the corticospinal tract on FLAIR: A simple and sensitive objective upper motor neuron degeneration marker in clinically verified amyotrophic lateral sclerosis.
    Jin J; Hu F; Zhang Q; Jia R; Dang J
    J Neurol Sci; 2016 Aug; 367():177-83. PubMed ID: 27423585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gray matter and white matter changes in non-demented amyotrophic lateral sclerosis patients with or without cognitive impairment: A combined voxel-based morphometry and tract-based spatial statistics whole-brain analysis.
    Christidi F; Karavasilis E; Riederer F; Zalonis I; Ferentinos P; Velonakis G; Xirou S; Rentzos M; Argiropoulos G; Zouvelou V; Zambelis T; Athanasakos A; Toulas P; Vadikolias K; Efstathopoulos E; Kollias S; Karandreas N; Kelekis N; Evdokimidis I
    Brain Imaging Behav; 2018 Apr; 12(2):547-563. PubMed ID: 28425061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brainstem pathology in amyotrophic lateral sclerosis and primary lateral sclerosis: A longitudinal neuroimaging study.
    Bede P; Chipika RH; Finegan E; Li Hi Shing S; Doherty MA; Hengeveld JC; Vajda A; Hutchinson S; Donaghy C; McLaughlin RL; Hardiman O
    Neuroimage Clin; 2019; 24():102054. PubMed ID: 31711033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal MRI quantification of the common neurostructural bases within the FTD-ALS continuum.
    Crespi C; Dodich A; Cappa SF; Canessa N; Iannaccone S; Corbo M; Lunetta C; Falini A; Cerami C
    Neurobiol Aging; 2018 Feb; 62():95-104. PubMed ID: 29131982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Region-specific impairment of the cervical spinal cord (SC) in amyotrophic lateral sclerosis: A preliminary study using SC templates and quantitative MRI (diffusion tensor imaging/inhomogeneous magnetization transfer).
    Rasoanandrianina H; Grapperon AM; Taso M; Girard OM; Duhamel G; Guye M; Ranjeva JP; Attarian S; Verschueren A; Callot V
    NMR Biomed; 2017 Dec; 30(12):. PubMed ID: 28926131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unbiased MRI Analyses Identify Micropathologic Differences Between Upper Motor Neuron-Predominant ALS Phenotypes.
    Rajagopalan V; Pioro EP
    Front Neurosci; 2019; 13():704. PubMed ID: 31354413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differing patterns of cortical grey matter pathology identified by multifractal analysis in UMN-predominant ALS patients with and without corticospinal tract hyperintensity.
    Rajagopalan V; Pioro EP
    J Neurol Sci; 2024 Apr; 459():122945. PubMed ID: 38564847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applying the D50 disease progression model to gray and white matter pathology in amyotrophic lateral sclerosis.
    Steinbach R; Batyrbekova M; Gaur N; Voss A; Stubendorff B; Mayer TE; Gaser C; Witte OW; Prell T; Grosskreutz J
    Neuroimage Clin; 2020; 25():102094. PubMed ID: 31896467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degeneration of gray and white matter differs between hypometabolic and hypermetabolic brain regions in a patient with ALS-FTD: a longitudinal MRI - PET multimodal study.
    Rajagopalan V; Pioro EP
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Feb; 22(1-2):127-132. PubMed ID: 32924608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Connectivity-based characterisation of subcortical grey matter pathology in frontotemporal dementia and ALS: a multimodal neuroimaging study.
    Bede P; Omer T; Finegan E; Chipika RH; Iyer PM; Doherty MA; Vajda A; Pender N; McLaughlin RL; Hutchinson S; Hardiman O
    Brain Imaging Behav; 2018 Dec; 12(6):1696-1707. PubMed ID: 29423814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graph network measures reveal distinct white matter abnormalities in motor and extra-motor brain regions of two UMN-predominant ALS subtypes.
    Rajagopalan V; Pioro EP
    J Neurol Sci; 2023 Sep; 452():120765. PubMed ID: 37672915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging and magnetic resonance spectroscopy in a patient with amyotrophic lateral sclerosis and frontotemporal dementia.
    Sarac H; Zagar M; Vranjes D; Henigsberg N; Bilić E; Pavlisa G
    Coll Antropol; 2008 Jan; 32 Suppl 1():205-10. PubMed ID: 18405084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative Brain MRI Metrics Distinguish Four Different ALS Phenotypes: A Machine Learning Based Study.
    Rajagopalan V; Chaitanya KG; Pioro EP
    Diagnostics (Basel); 2023 Apr; 13(9):. PubMed ID: 37174914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal structural changes in ALS: a three time-point imaging study of white and gray matter degeneration.
    Bede P; Hardiman O
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):232-241. PubMed ID: 29214883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Objective markers for upper motor neuron involvement in amyotrophic lateral sclerosis].
    Iwata NK
    Brain Nerve; 2007 Oct; 59(10):1053-64. PubMed ID: 17969345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of CSF NfL and tau in ALS.
    Schreiber S; Spotorno N; Schreiber F; Acosta-Cabronero J; Kaufmann J; Machts J; Debska-Vielhaber G; Garz C; Bittner D; Hensiek N; Dengler R; Petri S; Nestor PJ; Vielhaber S
    J Neurol; 2018 Nov; 265(11):2633-2645. PubMed ID: 30187162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.